94579 ⎘
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen or sulfur atoms
1, 2, 4-triazolone derivative and use thereof as an antagonist on the arginine-vasopressin 1B receptor
#302Bisaryl-bonded aryltriazolones and use thereof
#303Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#304Modulators of retinoid-related orphan receptor gamma
#305Novel HSP90 Inhibitor
#306Cyclic N,N′-diarylthioureas and N,N′-diarylureas-androgen receptor antagonists, anticancer agent, method for preparation and use thereof
#307Novel HSP90 Inhibitor
#308Novel HSP90 Inhibitor
#309Novel HSP90 Inhibitor
#310Hepatitis C virus inhibitors
#311Ester compound and use thereof
#312Regioselective chlorination of the phenyl ring of 4,5-dihydro-1-phenyl-1H-1,2,4-triazol-5-ones
#313TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#3141, 2, 4-triazole derivatives and their anti mycobacterial activity
#315Agonists of GPR131 and uses thereof
#316Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
#317Compounds, compositions and methods of using same for modulating uric acid levels
#318SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS
#319Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders
#320SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS
#321Triazole compounds that modulate Hsp90 activity
#322Method for Producing Triazolinthione Derivatives and Intermediates Thereof
#323Tyrosine bioconjugation through aqueous Ene-like reactions
#324S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
#325Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#326Sulfonyl-1,2,4-triazole salts
#327Compounds for inflammation and immune-related uses
#328Inhibition of glutaminase C
#329Neprilysin inhibitors
#330Triazole compounds that modulate HSP90 activity
#331PROCESSES FOR THE PREPARATION OF VARDENAFIL
#332Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
#333Compounds and compositions and methods of use
#334Neprilysin inhibitors
#335Neprilysin inhibitors
#336Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4-1,2,4-triazol-3-ylthio) acetate, and uses thereof
#337Triazole compounds that modulate HSP90 activity
#338Method of treating contrast-induced nephropathy
#339COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
#340Antifungal 1,2,4-triazolyl Derivatives
#341Triazole compounds that modulate Hsp90 activity
#342FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#343Five-membered heterocycles useful as serine protease inhibitors
#344Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent
#345Antifungal 1,2,4-triazolyl Derivatives
#346N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]--amino benzoic acids as HIV reverse transcriptase inhibitors
#347Antifungal 1,2,4-Triazolyl Derivatives Having a 5-Sulfur Substituent
#348TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY
#349Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity
#350SMALL MOLECULE MODULATORS OF CELL ADHESION
#351Substituted imidazole derivatives and methods of use thereof for treating cancer
#352MicroRNA Modulators and Method for Identifying And Using The Same
#353Compound with agitation effect on peroxisome proliferator-activated receptor process for its preparation and use thereof
#354Triazole compounds that modulate HSP90 activity
#355S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase
#356Hepatitis C virus inhibitors
#357Compounds and compositions and methods of use
#358Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
#359Compounds and compositions and methods of use
#360Methods for production of 1,2,4-triazol-3-one
#361Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
#362Substituted benzyl and phenylsulfonyl triazolones, and use thereof
#363Nitrooxy cycloalkane derivatives
#364Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
#365Methods for production of 1,2,4-triazol-3-one
#366S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase
#367METHOD TO INHIBIT ETHYLENE RESPONSES IN PLANTS
#368Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them
#369Insecticidal Benzenedicarboxamide Derivative
#370Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them
#371Sulphonyl-1,2,4-Triazole Salts
#372Lead, wiring member, package part, metal part provided with resin and resin-sealed semiconductor device, and methods for producing same
#373Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists
#374Crystalline modifications of prothioconazole
#375Inhibition of quorum sensing-mediated processes in bacteria
#376COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE
#377Triazolone derivatives
#378Triazole compounds that modulate HSP90 activity
#379Triazole compounds that modulate HSP90 activity
#380GLUCOKINASE ACTIVATORS
#381METHOD FOR TREATING INFECTIONS
#382Probes, Systems, and Methods for Drug Discovery
#383Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function
#384Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
#385Triazone compounds that modulate HSP90 activity
#386MATERIAL FORMED FROM DENDRITIC MOLECULES CONTAINING ASSOCIATIVE GROUPS
#387Heterocyclic antiviral compounds
#3881,4-disubstituted naphthalenes as inhibitors of p38 map kinase
#389Process for preparing triazolones
#390METHOD FOR TREATING INFLAMMATORY DISORDERS
#391Method for treating proliferative disorders associated with mutations in c-Met
#392ALPHA-KETOAMIDES AND DERIVATIVES THEREOF
#393Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#394S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
#395Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#3961, 2, 4-triazole derivatives as serotonergic modulators
#397Piperidine/piperazine derivatives
#398PESTICIDAL HETEROCYCLIC DIHALOALLYL COMPOUNDS
#399Triazolone derivatives
#400AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA
#401N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-amino benzoic acids as HIV reverse transcriptase inhibitors
#402HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES
#403Triazole derivative as an HSP 90 inhibitor
#404Triazole compounds that modulate HSP90 activity
#405PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS
#406Cytokine inhibitors
#407Cytokine inhibitors
#4082-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
#4092-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID AND METHYL ESTER
#410Compounds, compositions and methods of using same for modulating uric acid levels
#411Compounds, compositions and methods of using same for modulating uric acid levels
#412Compounds, compositions and methods of using same for modulating uric acid levels
#413Compounds, compositions and methods of using same for modulating uric acid levels
#414N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS
#415Organic compounds
#416SUBSTITUTED TRIAZOLINE, TETRAZOLONE AND IMIDAZOLONE DERIVATIVES FOR USE AS A MEDICINE
#417Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#418Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors
#419TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD
#420Aminoalkylphenols, methods of using and making the same
#421Sulphonyl-1,2,4-triazole salts
#422Difluorophenol derivatives and their use
#423SMALL MOLECULE MODULATORS OF CELL ADHESION
#424Inhibitors of GLYT1 transporters
#425Substituted amides
#426Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions
#427Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders
#428Antimicrobial agents
#429Compounds and compositions and methods of use
#430Methods of treating cancer with imidazolyl compounds
#431Non-nucleoside reverse transcriptase inhibitors
#432Synthesis and herbicidal activity of 1- (2-substituted benzo[d]thiazol-5-yl)-1H-1,2,4-triazol-5(4H)- one derivatives
#433Fungicide N-cyclopropyl-sulfonylamide derivatives
#434Triazole derivative
#435Sulphones which modulate the action of gamma secretase
#4361,2,4-TRIAZOLE ETHER DERIVATIVES AS MODULATORS OF MGLUR5
#437NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION
#438Room temperature molten salt and display element
#4393-triazolylphenyl sulfide derivative and insecticide, miticide and nematicide containing it as an active ingredient
#440Piperazine compounds
#441Piperazine compounds
#442PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS
#443Artichoke hybrid named ‘PS-H2015’
#444Five-membered heterocycles useful as serine protease inhibitors
#445Process for preparing triazolones
#446N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] --amino benzoic acids as HIV reverse transcriptase inhibitors
#447Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions
#448HSP90 inhibitor
#449Insecticidal 3-(dihaloalkenyl) phenyl derivatives
#450Substituted piperazines
#451Non-nucleoside reverse transcriptase inhibitors
#452Triazole derivatives
#453S-Triazolyl Alpha-Mercaptoacetanilides as Inhibitors of Hiv Reverse Transcriptase
#454Triazole compounds that modulate Hsp90 activity
#455Substituted pyridyoxy amides
#456Lisofylline analogs and methods for use
#457Ion Channel Modulators
#458Synthesis of triazole compounds that modulate HSP90 activity
#459(−)-enantiomer of the 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione
#460Novel Use
#461Triazole compounds that modulate HSP90 activity
#462SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS
#463Tricyclic aromatic and bis-phenyl sulfinyl derivatives
#464Novel cyclohexyl sulphones
#465Enzyme inhibitors
#4661,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
#467Compounds for the treatment of metabolic disorders
#468Compounds that modulate HSP90 activity and methods for identifying same
#469Compounds for the treatment of metabolic disorders
#470COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#471Triazolone derivatives
#472Triazole compounds that modulate HSP90 activity
#473Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides
#474Pesticidal heterocyclic dihaloallyl compounds
#475Ion Channel Modulators
#476COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#477Method for the treatment of metabolic disorders
#478Inhibition of cell proliferation
#479COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#480COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#481Method for the treatment of metabolic disorders
#482COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#483COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#484Aminoalkylphosphonates and related compounds as Edg receptor agonists
#485Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd
#486Sulphones which modulate the action of gamma-secretase
#487Ion channel modulators
#488GLUCOKINASE ACTIVATORS
#489Triazole compounds and their use as metabotropic glutamate receptor antagonists
#490Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#491Nonnucleoside reverse transcriptase inhibitors
#492Method for the production of tetrahydrogeranylacetone
#493Pesticidally active phenol derivatives
#494Methods for the treatment of metabolic disorders such as diabetes
#495Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
#496Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
#497Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
#498Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals
#499N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]--amino benozioc acids as HIV reverse transcriptase inhibitors
#500Sulfonylamino(thio)carbonyl compounds
#501Compounds and methods
#502Novel compounds for treatment of cancer and disorders associated with angiogenesis function
#503Selective herbicides based on substituted arylsulphonylaminocarbonyl-triazolinones and safeners
#504Substituted Heteroaryl- and Phenylsulfamoyl Compounds
#505Piperazine compounds
#506Heterocyclic reverse transcriptase inhibitors
#507Insecticidal phthalamide derivatives
#508Benzamide inhibitors of the P2X7 receptor
#509Compound inhibiting in vivo phosphorous transport and medicine containing the same
#510N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#511Compounds, compositions, and methods
#512Substituted alcohols useful in treatment of Alzheimer's disease
#513Compounds for inflammation and immune-related uses
#514Triazole compounds that modulate Hsp90 activity
#515Compounds for the treatment of CNS and amyloid associated diseases
#516CXCR3 antagonists
#517Heterocycle grafted monomers and related polymers and hybrid inorganic-organic polymer membranes
#518Crystal modification II of 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxy-propyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione
#519Pharmaceutical use of substituted 1,2,4-triazoles
#520Aminoalkylphosphonates and related compounds as Edg receptor agonists
#5211,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
#522Benzamide, heteroarylamide and reverse amides
#523Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
#524Cyclohexyl sulphones
#525Heterocyclic antiviral compounds
#526Triazole derivative
#527Triazole compounds and their use as metabotropic glutamate receptor antagonists
#528Certain triazole-based compounds, compositions, and uses thereof
#529Substituted heteroaryl- and phenylsulfamoyl compounds
#530Non nucleoside reverse transcriptase inhibitors
#531Five-membered heterocycles useful as serine protease inhibitors
#532Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts
#533Compounds for the treatment of metabolic disorders
#534Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
#535Aminoalkylphenols, methods of using and making the same
#536Substituted amides
#537Tricyclic aromatic and bis-phenyl sulfinyl derivatives
#538Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
#539Triazole derivatives and method of using the same to treat HIV infections
#540Triazoles as oxytocin antagonists
#5415-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
#542Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
#543Alpha-ketoamides and derivatives thereof
#544Aminoalkylphosphonates and related compounds as edg receptor agonists
#545Fungicidal mixtures based on prothioconazole and a strobilurin derivative
#546Compound for the treatment of metabolic disorders
#547Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
#548Substituted benzoylisoxazoles and the use thereof as herbicides
#549CXCR3 antagonists
#550Perfluorinated amide salts and their uses as ionic conducting materials
#55111-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
#552Method to inhibit ethylene responses in plants
#553Non-nucleoside reverse transcriptase inhibitors
#554Butyric acid derivatives
#555Enzyme inhibitors
#556Azole compounds, process for preparation of the same and use thereof
#557Substituted aryl ketones
#558Compounds for the treatment of metabolic disorders
#5593-(3-fluorophenyl)-5-(4-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole as an antimicrobial compound
#560Ethyl 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetate as an antimicrobial compound
#5616-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexanoic acid as an antimicrobial compound
#562Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound
#563Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound
#5644-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoic acid as an antimicrobial compound
#565Ethyl 3-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4- triazol-3-ylthio)propanoate as an antimicrobial compound
#566Ethyl 6-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexanoate as an antimicrobial compound
#567Ethyl {[4-benzoyl-5-(3-fluorophenyl)-4H-1,2,4-triazol-3-yl]thio}acetate as an antimicrobial compound
#5684-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agents